Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Insmed Inc shares valued at $11,129,927 were sold by Schaeffer Orlov S Nicole on Sep 12 ’25. At $145.45 per share, Schaeffer Orlov S Nicole sold 76,520 shares. The insider’s holdings dropped to 36,461 shares worth approximately $5.57 million following the completion of this transaction.
Also, SHAROKY MELVIN MD sold 10,000 shares, netting a total of over 1,453,900 in proceeds. Following the sale of shares at $145.39 each, the insider now holds 262,675 shares.
Before that, Schaeffer Orlov S Nicole had added 76,520 shares to its account. In a trade valued at $11,127,662, the Officer bought Insmed Inc shares for $145.42 each.
As published in their initiating research note from William Blair on August 20, 2025, Insmed Inc [INSM] has been an Outperform. Analysts at Morgan Stanley downgraded the stock from ‘”an Overweight”‘ to ‘”an Equal-weight”‘ outlook in a report released in mid August. As of May 13, 2025, Jefferies has initiated its “Buy” rating for INSM. Earlier on February 25, 2025, RBC Capital Mkts initiated its rating. Their recommendation was “an Outperform” for INSM stock.
Analyzing INSM Stock Performance
On last trading session, Insmed Inc [NASDAQ: INSM] rose 3.75% to $152.8. The stock’s lowest price that day was $145.2401, but it reached a high of $152.85 in the same session. During the last five days, there has been a surge of approximately 12.69%. Over the course of the year, Insmed Inc shares have jumped approximately 109.32%. Shares of the company reached a 52-week high of $152.85 on 10/02/25 and a 52-week low of $60.40 on 04/09/25.
Support And Resistance Levels for Insmed Inc (INSM)
According to the 24-hour chart, there is a support level at 147.74, which, if violated, would cause prices to drop to 142.69. In the upper region, resistance lies at 155.35. The next price resistance is at 157.91. RSI (Relative Strength Index) is 70.02 on the 14-day chart, showing overbought technical sentiment.
Is Insmed Inc subject to short interest?
Stocks of Insmed Inc saw a sharp rise in short interest on 2025-09-15 jumping by 78713.0 shares to 10.58 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 10.5 million shares. A jump of 0.74% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.62 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.62.
Which companies own the most shares of Insmed Inc (INSM)?
In terms of Insmed Inc share price expectations, FactSet research, analysts set an average price target of 160 in the next 12 months, up nearly 8.64% from the previous closing price of $147.28. Analysts anticipate Insmed Inc stock to reach 180 by 2025, with the lowest price target being 140. In spite of this, 14 analysts ranked Insmed Inc stock as Buy at the end of 2025. On April 23, 2024, Truist assigned a price target of “a Buy” to the stock and initiated coverage with a $48.
